# Oxytocin Treatment of Alcohol Dependence

> **NCT02275611** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 13 (actual)

## Conditions studied

- Alcohol Withdrawal
- Alcohol Dependence

## Interventions

- **DRUG:** intranasal oxytocin spray
- **DRUG:** Intranasal Placebo Spray

## Key facts

- **NCT ID:** NCT02275611
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02275611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02275611, "Oxytocin Treatment of Alcohol Dependence". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02275611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
